Reckitt Asks FDA To Require Opioid Drug Childproofing

Law360, New York (September 27, 2012, 2:31 PM EDT) -- Reckitt Benckiser Pharmaceuticals Inc. has issued a citizen petition asking the U.S. Food and Drug Administration to require all manufacturers of semi-synthetic opioids to implement safeguards to prevent accidental exposure to children, Reckitt said Tuesday.

Reckitt said its petition was spurred by recent data finding the rate of accidental use by children of pill-form buprenorphine — a semi-synthetic opioid used as a painkiller in low dosages and as a treatment for opioid addiction in high dosages — was up to 8.5 times higher than seen with...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.